IRIDEX CORP Increase (Decrease) in Due from Related Parties
IRIDEX CORP (IRIX) reported Increase (Decrease) in Due from Related Parties of -$517.00 thousand for the 6-month period ending 2026-07-04, per its 10-Q filed 2026-08-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueFromRelatedParties · last filed 2026-08-18
- IRIDEX CORP increase (decrease) in due from related parties for the quarter ending 2026-07-04 was -$157.00K, a 183.96% decline year-over-year.
- IRIDEX CORP increase (decrease) in due from related parties for the quarter ending 2026-04-04 was -$360.00K, a 236.88% decline year-over-year.
- IRIDEX CORP increase (decrease) in due from related parties for the quarter ending 2026-01-03 was -$466.00K, a 175.53% decline year-over-year.
- IRIDEX CORP increase (decrease) in due from related parties for the quarter ending 2025-09-27 was -$495.00K, a 1033.96% decline year-over-year.
- IRIDEX CORP increase (decrease) in due from related parties for fiscal 2026 was -$511.00K.
- IRIDEX CORP increase (decrease) in due from related parties for fiscal 2024 was -$484.00K.
- IRIDEX CORP increase (decrease) in due from related parties for fiscal 2023 was -$612.00K, a 241.34% decline from fiscal 2022.
- IRIDEX CORP increase (decrease) in due from related parties for fiscal 2022 was $433.00K, a 86.06% decline from fiscal 2022.
| Period end | Increase (Decrease) in Due from Related Parties 3 month | Increase (Decrease) in Due from Related Parties 6 month | Increase (Decrease) in Due from Related Parties 9 month | Increase (Decrease) in Due from Related Parties 12 month |
|---|---|---|---|---|
| 2026-07-04 | -$157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-18 | -$517.00K 10-Q · filed 2026-08-18 | -$983.00K derived: sum of 3 quarters · filed 2026-08-18 | -$1.48M derived: sum of 4 quarters · filed 2026-08-18 |
| 2026-04-04 | -$360.00K 10-Q · filed 2026-05-19 | -$826.00K derived: sum of 2 quarters · filed 2026-05-19 | -$1.32M derived: sum of 3 quarters · filed 2026-05-19 | -$1.13M derived: sum of 4 quarters · filed 2026-08-18 |
| 2026-01-03 | -$466.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-02 | -$961.00K derived: sum of 2 quarters · filed 2026-04-02 | -$774.00K derived: sum of 3 quarters · filed 2026-08-18 | -$511.00K 10-K · filed 2026-04-02 |
| 2025-09-27 | -$495.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$308.00K derived: sum of 2 quarters · filed 2026-08-18 | -$45.00K 10-Q · filed 2025-11-12 | $572.00K derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-06-28 | $187.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-18 | $450.00K 10-Q · filed 2026-08-18 | $1.07M derived: sum of 3 quarters · filed 2026-08-18 | $1.12M derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-03-29 | $263.00K 10-Q · filed 2026-05-19 | $880.00K derived: sum of 2 quarters · filed 2026-05-19 | $933.00K derived: sum of 3 quarters · filed 2026-05-19 | $85.00K derived: sum of 4 quarters · filed 2026-05-19 |
| 2024-12-28 | $617.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-02 | $670.00K derived: sum of 2 quarters · filed 2026-04-02 | -$178.00K derived: sum of 3 quarters · filed 2026-04-02 | -$484.00K 10-K · filed 2026-04-02 |
| 2024-09-28 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$795.00K derived: sum of 2 quarters · filed 2025-11-12 | -$1.10M 10-Q · filed 2025-11-12 | -$179.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-29 | -$848.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.15M 10-Q · filed 2025-08-12 | -$232.00K derived: sum of 3 quarters · filed 2025-08-12 | -$609.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-30 | -$306.00K 10-Q · filed 2025-05-13 | $616.00K derived: sum of 2 quarters · filed 2025-05-13 | $239.00K derived: sum of 3 quarters · filed 2025-05-13 | -$1.21M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-30 | $922.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $545.00K derived: sum of 2 quarters · filed 2025-03-27 | -$901.00K derived: sum of 3 quarters · filed 2025-03-27 | -$612.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$377.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$1.82M derived: sum of 2 quarters · filed 2024-11-12 | -$1.53M 10-Q · filed 2024-11-12 | -$1.58M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-07-01 | -$1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.16M 10-Q · filed 2024-08-08 | -$1.21M derived: sum of 3 quarters · filed 2024-08-08 | -$47.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-04-01 | $289.00K 10-Q · filed 2024-05-14 | $241.00K derived: sum of 2 quarters · filed 2024-05-14 | $1.40M derived: sum of 3 quarters · filed 2024-05-14 | $419.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $1.11M derived: sum of 2 quarters · filed 2024-03-29 | $130.00K derived: sum of 3 quarters · filed 2024-03-29 | $433.00K 10-K · filed 2024-03-29 |
| 2022-10-01 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $178.00K derived: sum of 2 quarters · filed 2023-11-20 | $481.00K 10-Q · filed 2023-11-20 | $1.57M derived: sum of 4 quarters · filed 2023-11-20 |
| 2022-07-02 | -$980.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$677.00K 10-Q · filed 2022-08-15 | $411.00K derived: sum of 3 quarters · filed 2023-08-10 | $1.05M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-04-02 | $303.00K 10-Q · filed 2023-05-11 | $1.39M derived: sum of 2 quarters · filed 2023-05-11 | $2.03M derived: sum of 3 quarters · filed 2023-05-11 | |
| 2022-01-01 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $1.73M derived: sum of 2 quarters · filed 2023-03-09 | $3.11M 10-K · filed 2023-03-09 | |
| 2021-10-02 | $640.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.02M 10-Q · filed 2022-11-10 | ||
| 2021-07-03 | $1.38M 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |